共 302 条
[1]
Loke YK(2010)Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis Thorax 65 884-890
[2]
Kwok CS(2010)Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis Thorax 65 878-883
[3]
Niruban A(2006)CRB-65 predicts death from community-acquired pneumonia J Intern Med 260 93-101
[4]
Myint PK(2008)CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 63 665-666
[5]
Chalmers JD(2009)Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany Pneumologie 63 e1-e68
[6]
Singanayagam A(2008)Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Eur Respir J 31 349-355
[7]
Akram AR(2009)Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome Crit Care 13 R38-93
[8]
Mandal P(2006)Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 84-214
[9]
Short PM(2010)Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ Thorax 65 208-1434
[10]
Choudhury G(2010)Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 1426-127